Bayer Group
Consolidated Statements of Cash Flows

 

 

Q3 2015

Q3 2016

 

9M 2015

9M 2016

 

 

€ million

€ million

 

€ million

€ million

2015 figures restated

Income from continuing operations after income taxes

 

994

1,216

 

3,422

4,140

Income taxes

 

298

305

 

1,057

1,210

Financial result

 

280

274

 

841

903

Income taxes paid or accrued

 

(688)

(499)

 

(1,751)

(1,664)

Depreciation, amortization and impairments

 

760

765

 

2,375

2,618

Change in pension provisions

 

(147)

(101)

 

(272)

(312)

(Gains) losses on retirements of noncurrent assets

 

(63)

(9)

 

(76)

(14)

Gross cash flow

 

1,434

1,951

 

5,596

6,881

Decrease (increase) in inventories

 

(277)

(111)

 

(447)

(40)

Decrease (increase) in trade accounts receivable

 

730

924

 

(1,255)

(574)

(Decrease) increase in trade accounts payable

 

(43)

(107)

 

(358)

(961)

Changes in other working capital, other noncash items

 

388

380

 

1,375

275

Net cash provided by (used in) operating activities (net cash flow) from continuing operations

 

2,232

3,037

 

4,911

5,581

Net cash provided by (used in) operating activities (net cash flow) from discontinued operations

 

98

16

 

102

776

Net cash provided by (used in) operating activities (net cash flow) (total)

 

2,330

3,053

 

5,013

6,357

Cash outflows for additions to property, plant, equipment and intangible assets

 

(655)

(656)

 

(1,601)

(1,608)

Cash inflows from the sale of property, plant, equipment and other assets

 

81

14

 

165

53

Cash inflows from divestitures

 

2

 

2

8

Cash inflows from (outflows for) noncurrent financial assets

 

258

(41)

 

(78)

(649)

Cash outflows for acquisitions less acquired cash

 

(162)

 

(159)

2

Interest and dividends received

 

21

38

 

89

75

Cash inflows from (outflows for) current financial assets

 

(510)

(1,394)

 

(506)

(1,627)

Net cash provided by (used in) investing activities (total)

 

(965)

(2,039)

 

(2,088)

(3,746)

Dividend payments

 

(3)

(2)

 

(1,869)

(2,122)

Issuances of debt

 

4,445

4,454

 

11,647

12,122

Retirements of debt

 

(6,383)

(5,008)

 

(11,559)

(12,717)

Interest paid including interest-rate swaps

 

(284)

(290)

 

(571)

(590)

Interest received from interest-rate swaps

 

63

 

114

49

Cash outflows for the purchase of additional interests in subsidiaries

 

 

Net cash provided by (used in) financing activities (total)

 

(2,162)

(846)

 

(2,238)

(3,258)

Change in cash and cash equivalents due to business activities (total)

 

(797)

168

 

687

(647)

Cash and cash equivalents at beginning of period

 

3,247

1,055

 

1,853

1,859

Change in cash and cash equivalents due to changes in scope of consolidation

 

2

 

5

(2)

Change in cash and cash equivalents due to exchange rate movements

 

(57)

9

 

(150)

22

Cash and cash equivalents at end of period

 

2,395

1,232

 

2,395

1,232